We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

49 hedge funds and large institutions have $93.1M invested in VanEck Pharmaceutical ETF in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

4% more funds holding

Funds holding: 47 → 49 (+2)

14.75% less ownership

Funds ownership: 51.64% → 36.88% (-15%)

23% less capital invested

Capital invested by funds: $122M → $93.1M (-$28.5M)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

71% less call options, than puts

Call options by funds: $9.18M | Put options by funds: $31.7M

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
16
Closed
6
Calls
$9.18M
Puts
$31.7M
Net Calls
-$22.5M
Net Calls Change
+$1.48M

Top Buyers

Rank Fund Capital Flow
1
CCP
Clough Capital Partners
Massachusetts
+$21.2M
2
22CM
20/20 Capital Management
California
+$5.81M
3
Stifel Financial
Stifel Financial
Missouri
+$764K
4
RFWA
RPg Family Wealth Advisory
Massachusetts
+$204K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$113K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$32M
2
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
-$22.1M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.89M
4
BCI
Brinker Capital Investments
Pennsylvania
-$2.06M
5
IMC Chicago
IMC Chicago
Illinois
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
26
Glenmede Trust
Pennsylvania
$66K – – –
TCM
27
Tradewinds Capital Management
Washington
$66K – – –
NSIM
28
North Star Investment Management
Illinois
$65K +$64 +1 +0.1%
TRCT
29
Tower Research Capital (TRC)
New York
$65K +$29.9K +466 +92%
LWM
30
Liberty Wealth Management
California
$40K +$256 +4 +0.7%
LS
31
Leelyn Smith
Illinois
$30K +$3.4K +53 +13%
Citigroup
32
Citigroup
New York
$29K – – –
FDCDDQ
33
Federation des caisses Desjardins du Quebec
Quebec, Canada
$26.6K – – –
S
34
SignatureFD
Georgia
$24K +$22.7K +355 New
MIM
35
Macroview Investment Management
Maryland
$20K – – –
EIP
36
Ellis Investment Partners
Pennsylvania
$18K +$64 +1 +0.4%
IA
37
IFP Advisors
Florida
$15K -$1.47K -23 -9%
FWM
38
Focused Wealth Management
New York
$15K +$14.2K +222 New
AF
39
Advisornet Financial
Minnesota
$14K – – –
Fidelity Investments
40
Fidelity Investments
Massachusetts
$13K – – –
JCM
41
Jacobi Capital Management
Pennsylvania
$13K – – –
TWM
42
Tradition Wealth Management
Minnesota
$13K +$12.5K +195 New
ADL
43
Asset Dedication LLC
California
$10K – – –
HCM
44
Highlander Capital Management
New Jersey
$9K – – –
Barclays
45
Barclays
United Kingdom
$7K – – –
SFS
46
Sowell Financial Services
Arkansas
$7K – – –
SWA
47
SOA Wealth Advisors
New York
$7K +$7.05K +110 New
SPIA
48
Steward Partners Investment Advisory
New York
$5K – – –
AIM
49
Anchor Investment Management
South Carolina
$3.85K – – –
IMC Chicago
50
IMC Chicago
Illinois
– -$1.35M -21,667 Closed
1
2
3

PPH Hedge Fund Activity: Q4 2020 in Review

49 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q4 2020, worth a combined $93.1M — down 23% from $122M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PPH positions and 6 closed out — a net gain of 2 holders — while 9 added to existing stakes and 16 trimmed.

The largest buyer was Clough Capital Partners, opening a new position worth an estimated $21.2M. The largest seller was Bank of America, cutting an estimated $32M.

  • 49 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q4 2020, up from 47 in Q3 2020.
  • Funds reported $93.1M of VanEck Pharmaceutical ETF stock for Q4 2020, down 23% quarter-over-quarter.
  • 8 funds opened new VanEck Pharmaceutical ETF positions in Q4 2020 and 6 closed out, a net change of +2 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q4 2020 was Clough Capital Partners, an estimated $21.2M added.
  • The largest VanEck Pharmaceutical ETF seller in Q4 2020 was Bank of America, an estimated $32M sold.

Based on aggregated 13F filings for Q4 2020.